- Home
- USCB vs ANGO Comparison
USCB vs ANGO Comparison
Compare USCB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- ANGO
- Stock Information
- Founded
- USCB 2002
- ANGO 1988
- Country
- USCB United States
- ANGO United States
- Employees
- USCB N/A
- ANGO N/A
- Industry
- USCB Major Banks
- ANGO Medical/Dental Instruments
- Sector
- USCB Finance
- ANGO Health Care
- Exchange
- USCB Nasdaq
- ANGO Nasdaq
- Market Cap
- USCB 316.4M
- ANGO 406.9M
- IPO Year
- USCB 2021
- ANGO 2004
- Fundamental
- Price
- USCB $17.02
- ANGO $9.52
- Analyst Decision
- USCB Buy
- ANGO Strong Buy
- Analyst Count
- USCB 3
- ANGO 2
- Target Price
- USCB $20.50
- ANGO $14.00
- AVG Volume (30 Days)
- USCB 23.7K
- ANGO 674.5K
- Earning Date
- USCB 07-24-2025
- ANGO 07-15-2025
- Dividend Yield
- USCB 2.42%
- ANGO N/A
- EPS Growth
- USCB 78.48
- ANGO N/A
- EPS
- USCB 1.39
- ANGO N/A
- Revenue
- USCB $84,457,000.00
- ANGO $283,320,000.00
- Revenue This Year
- USCB $23.28
- ANGO N/A
- Revenue Next Year
- USCB $7.02
- ANGO $6.35
- P/E Ratio
- USCB $11.90
- ANGO N/A
- Revenue Growth
- USCB 34.16
- ANGO N/A
- 52 Week Low
- USCB $11.88
- ANGO $5.47
- 52 Week High
- USCB $21.86
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- USCB 52.33
- ANGO 39.36
- Support Level
- USCB $16.08
- ANGO $9.68
- Resistance Level
- USCB $16.59
- ANGO $10.24
- Average True Range (ATR)
- USCB 0.33
- ANGO 0.43
- MACD
- USCB 0.07
- ANGO -0.14
- Stochastic Oscillator
- USCB 63.52
- ANGO 2.75
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.